Insider Selling: Intuitive Surgical (NASDAQ:ISRG) EVP Sells 46 Shares of Company Stock

Intuitive Surgical logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Intuitive Surgical EVP Mark Brosius sold 46 shares for $18,733 at an average price of $407.24 under a pre-arranged Rule 10b5-1 plan, reducing his position by 16.85%. He retained 227 shares after the sale.
  • The company reported quarterly earnings of $3.00 per share, beating the $2.65 analyst consensus, while revenue of $3.05 billion exceeded estimates and rose 21.7% year over year.
  • Analysts have a consensus “Moderate Buy” rating and an average price target of $495.90; shares closed at $399.06 on Friday.
  • MarketBeat previews top five stocks to own in December.

Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) EVP Mark Brosius sold 46 shares of the firm's stock in a transaction dated Friday, November 20th. The stock was sold at an average price of $407.24, for a total value of $18,733.04. Following the sale, the executive vice president directly owned 227 shares in the company, valued at $92,443.48. This trade represents a 16.85% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Mark Brosius also recently made the following trade(s):

  • On Wednesday, November 18th, Mark Brosius sold 46 shares of Intuitive Surgical stock. The stock was sold at an average price of $430.63, for a total value of $19,808.98.
  • On Monday, November 16th, Mark Brosius sold 46 shares of Intuitive Surgical stock. The shares were sold at an average price of $444.38, for a total value of $20,441.48.
  • On Wednesday, October 28th, Mark Brosius sold 61 shares of Intuitive Surgical stock. The shares were sold at an average price of $441.60, for a total transaction of $26,937.60.
  • On Monday, October 26th, Mark Brosius sold 61 shares of Intuitive Surgical stock. The shares were sold at an average price of $451.75, for a total transaction of $27,556.75.
  • On Friday, September 11th, Mark Brosius sold 25 shares of Intuitive Surgical stock. The shares were sold at an average price of $365.79, for a total value of $9,144.75.
  • On Wednesday, September 9th, Mark Brosius sold 23 shares of Intuitive Surgical stock. The shares were sold at an average price of $350.20, for a total value of $8,054.60.
  • On Tuesday, September 8th, Mark Brosius sold 46 shares of Intuitive Surgical stock. The shares were sold at an average price of $361.23, for a total value of $16,616.58.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG traded down $8.18 during trading on Friday, reaching $399.06. The company had a trading volume of 2,689,871 shares, compared to its average volume of 2,435,572. The firm has a market capitalization of $138.33 billion, a price-to-earnings ratio of 48.25, a price-to-earnings-growth ratio of 2.90 and a beta of 1.45. Intuitive Surgical, Inc. has a fifty-two week low of $328.57 and a fifty-two week high of $603.88. The stock's fifty day moving average price is $423.51 and its 200 day moving average price is $427.91.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share for the quarter, topping analysts' consensus estimates of $2.65 by $0.35. The firm had revenue of $3.05 billion for the quarter, compared to analyst estimates of $2.91 billion. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. Intuitive Surgical's quarterly revenue was up 21.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $2.40 earnings per share. On average, equities analysts anticipate that Intuitive Surgical, Inc. will post 9.37 EPS for the current fiscal year.

Analysts Set New Price Targets

ISRG has been the subject of several research reports. Sanford C. Bernstein restated an "outperform" rating on shares of Intuitive Surgical in a research report on Wednesday, August 12th. Robert W. Baird raised their price target on shares of Intuitive Surgical from $513.00 to $550.00 and gave the stock an "outperform" rating in a research note on Wednesday, October 21st. BMO Capital Markets reissued an "outperform" rating on shares of Intuitive Surgical in a research report on Tuesday. UBS Group reissued a "buy" rating on shares of Intuitive Surgical in a research report on Tuesday, October 13th. Finally, Royal Bank Of Canada dropped their target price on Intuitive Surgical from $575.00 to $550.00 and set an "outperform" rating on the stock in a research report on Wednesday, October 21st. One equities research analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $495.90.

Check Out Our Latest Analysis on Intuitive Surgical

Key Intuitive Surgical News

Investors following ISRG have been watching these news items:

  • Positive Sentiment: Industry coverage casts Intuitive Surgical as a leading beneficiary of expanding surgical-robotics adoption, citing growth in robotic procedures and use of its da Vinci system. A separate medical-device roundup also identifies ISRG as a stock to watch, though neither story reports a new company announcement. Surgical robotics industry article Medical-device stocks article
  • Neutral Sentiment: Options-market coverage notes activity that investors may want to watch, but provides no clear directional conclusion or confirmed catalyst. Options-market article
  • Negative Sentiment: ISRG was reported down 1.7% since its latest earnings report, suggesting the strong results have not yet translated into sustained share-price momentum. The article offers no fresh earnings-estimate change to clarify the potential for a rebound. Post-earnings performance article

Institutional Trading of Intuitive Surgical

Hedge funds have recently made changes to their positions in the stock. Bank of New York Mellon Corp bought a new position in shares of Intuitive Surgical during the second quarter worth about $1,335,753,000. Arrowstreet Capital Limited Partnership boosted its position in Intuitive Surgical by 95.3% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider's stock worth $970,635,000 after acquiring an additional 1,027,475 shares during the period. Assenagon Asset Management S.A. grew its stake in shares of Intuitive Surgical by 55.8% in the third quarter. Assenagon Asset Management S.A. now owns 1,557,940 shares of the medical equipment provider's stock worth $633,505,000 after purchasing an additional 558,099 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. bought a new position in shares of Intuitive Surgical in the third quarter worth $136,743,000. Finally, Voya Investment Management LLC increased its holdings in shares of Intuitive Surgical by 97.2% during the third quarter. Voya Investment Management LLC now owns 491,914 shares of the medical equipment provider's stock valued at $200,028,000 after purchasing an additional 242,468 shares during the period. Institutional investors own 83.64% of the company's stock.

About Intuitive Surgical

(Get Free Report)

Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.

Recommended Stories

Insider Buying and Selling by Quarter for Intuitive Surgical (NASDAQ:ISRG)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Intuitive Surgical Right Now?

Before you consider Intuitive Surgical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.

While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines